Higher Order Structure of Proteins in Biopharmaceutical Development
Official in USP 41–NF 36, published Nov 1, 2017 | Official Date: May 1, 2018.
|Documentary Standards||Associated Reference Standards|
|Erythropoietin RS (Released)|
|Released Reference Standards||NEW Reference Standards in Development|
CHO Genomic DNA (To be released end of 2018)
E. coli Genomic DNA (To be released end of 2018)
Filgrastim for Bioassay
Interferon Beta 1A
Interferon Beta 1A for Bioidentity
Proposed New/Revised Documentary Standards
|<xxxx> Biologics Stability||
New General Chapter in development.
Free Official General Chapter Downloads
- <124> Erythropoietin Bioassays
- <129> Analytical Procedures for Recombinant Therapeutic Monoclonal Antibodies
- <210> Monosaccharide Analysis
- <212> Oligosaccharide Analysis
- <1132> Residual Host Cell Protein Measurement in Biopharmaceuticals
- <507> Protein Determination Procedures
- <509> Residual DNA Testing
New Reference Standards Releases
Sign up to receive notices when new reference standards become available.
Collaborative Testing Opportunities
We are seeking collaborative test sites for the following proteins:
- Interferon Beta 1a for Bioidentity
Protein Standards–Collaborate with USP
Building on the experience in setting standards for therapeutic proteins, USP is exploring opportunities to develop standards that are applicable across protein products. Areas for consideration are bioassay standards, chromatographic system suitability standards, and standards for critical reagents, in addition to standards for raw materials. USP welcomes recommendations from stakeholders regarding standards which would be useful in the development and release of therapeutic proteins. Comments and queries should be addressed to email@example.com.
As the role of biologic drugs continues to expand in the therapeutic arena, USP is committed to collaborating with scientific leaders in the biopharmaceutical community to update existing and develop new quality standards that support activities in the discovery, development, manufacturing, and distribution of biologics. Learn more about the development and revision process and how you can get involved.
USP is actively seeking sponsors for the modernization of the following protein monographs:
- Papain Tablets for Topical Solution
- Lactase Tablets
- Sargramostim for Injection
- Hyaluronidase for Injection
To learn more about modernization, please contact us, at firstname.lastname@example.org
Our work with proteins is guided by scientific experts from a variety of disciplines and industries. Find out what these Expert Committees are up to by reviewing their workplans: